mounjaro tirzepatide pen - with injection is an antidiabetic medication used for the treatment of diabetes and to lose weight. Focus on foreground. Copenhagen, Denmark - November 13, 2023 dependent insulinotropic polypeptide (GIP) and glucagon How to use Mounjaro (tirzepatide)

Understanding the prescribing information can help you make an informed decision

Journal reference: Alshehri, G.H., Al-Kuraishy, H.M., Waheed, H.J., Al-Gareeb, A.I., Faheem, S.A., Alexiou, A., Papadakis, M

Tirzepatide for type 2 diabetes (Mounjaro) is available in pre-filled single-dose pens or single-dose vials in the following strengths per 0.5 mL: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes, has demonstrated significant weight loss effects in clinical trialswith some patients losing 15% or more of their body weight over 68 weeks

The FDA said that it has received reports of adverse events in people who used compounded semaglutide and that patients should not use a compounded drug if an approved drug is available. Ozempic and Wegovy have been on the FDAs Drug Shortages list since last year